These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Apolipoprotein C-I expression in the brain in Alzheimer's disease. Petit-Turcotte C, Stohl SM, Beffert U, Cohn JS, Aumont N, Tremblay M, Dea D, Yang L, Poirier J, Shachter NS. Neurobiol Dis; 2001 Dec 15; 8(6):953-63. PubMed ID: 11741391 [Abstract] [Full Text] [Related]
9. Differences in the Abeta40/Abeta42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype. Fagan AM, Younkin LH, Morris JC, Fryer JD, Cole TG, Younkin SG, Holtzman DM. Ann Neurol; 2000 Aug 15; 48(2):201-10. PubMed ID: 10939571 [Abstract] [Full Text] [Related]
11. Differential levels of apolipoprotein E and butyrylcholinesterase show strong association with pathological signs of Alzheimer's disease in the brain in vivo. Darreh-Shori T, Forsberg A, Modiri N, Andreasen N, Blennow K, Kamil C, Ahmed H, Almkvist O, Långström B, Nordberg A. Neurobiol Aging; 2011 Dec 15; 32(12):2320.e15-32. PubMed ID: 20538374 [Abstract] [Full Text] [Related]
12. Increased CSF-BACE 1 activity is associated with ApoE-epsilon 4 genotype in subjects with mild cognitive impairment and Alzheimer's disease. Ewers M, Zhong Z, Bürger K, Wallin A, Blennow K, Teipel SJ, Shen Y, Hampel H. Brain; 2008 May 15; 131(Pt 5):1252-8. PubMed ID: 18334538 [Abstract] [Full Text] [Related]
13. Increased levels of neuronal thread protein in cerebrospinal fluid of patients with Alzheimer's disease. de la Monte SM, Volicer L, Hauser SL, Wands JR. Ann Neurol; 1992 Dec 15; 32(6):733-42. PubMed ID: 1471863 [Abstract] [Full Text] [Related]
15. CSF lipoproteins and Alzheimer's disease. Neely MD, Montine TJ. J Nutr Health Aging; 2002 Dec 15; 6(6):383-91. PubMed ID: 12459889 [Abstract] [Full Text] [Related]
16. Widespread distribution of PLTP in human CNS: evidence for PLTP synthesis by glia and neurons, and increased levels in Alzheimer's disease. Vuletic S, Jin LW, Marcovina SM, Peskind ER, Moller T, Albers JJ. J Lipid Res; 2003 Jun 15; 44(6):1113-23. PubMed ID: 12671035 [Abstract] [Full Text] [Related]
18. Altered kallikrein 7 and 10 concentrations in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia. Diamandis EP, Scorilas A, Kishi T, Blennow K, Luo LY, Soosaipillai A, Rademaker AW, Sjogren M. Clin Biochem; 2004 Mar 15; 37(3):230-7. PubMed ID: 14972646 [Abstract] [Full Text] [Related]
19. [Characterization of sialo-apolipoprotein E in human cerebrospinal fluid]. Yamauchi K. Rinsho Byori; 2009 May 15; 57(5):436-44. PubMed ID: 19522249 [Abstract] [Full Text] [Related]
20. Plasma apolipoprotein E concentration is an important determinant of phospholipid transfer protein activity in type 2 diabetes mellitus. Tan KC, Shiu SW, Wong Y, Wong WK, Tam S. Diabetes Metab Res Rev; 2006 May 15; 22(4):307-12. PubMed ID: 16389649 [Abstract] [Full Text] [Related] Page: [Next] [New Search]